gcmaf.se | GcMAF.se - Buy GcMAF | Boost Immune System

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://gcmaf.se/sitemap_index.xml # --------------------------- # END YOAST

Meta Tags

Title	GcMAF.se - Buy GcMAF \| Boost Immune System \| Destroy
Description	GcMAF rebuilds the Immune system to destroy cancer, infections and chronic diseases. GcMAF with 9 tests, two of them live cell activity
Keywords	N/A

Server Information

WebSite	gcmaf.se
Host IP	172.67.134.104
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

gcmaf.se Valuation

US$602,327

Last updated: 2023-05-13 05:49:38

gcmaf.se has Semrush global rank of 17,572,375. gcmaf.se has an estimated worth of US$ 602,327, based on its estimated Ads revenue. gcmaf.se receives approximately 69,500 unique visitors each day. Its web server is located in United States, with IP address 172.67.134.104. According to SiteAdvisor, gcmaf.se is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$602,327
Daily Ads Revenue	US$556
Monthly Ads Revenue	US$16,680
Yearly Ads Revenue	US$200,158
Daily Unique Visitors	4,634
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
gcmaf.se.	A	300	IP: 172.67.134.104
gcmaf.se.	A	300	IP: 104.21.25.170
gcmaf.se.	AAAA	300	IPV6: 2606:4700:3033::6815:19aa
gcmaf.se.	AAAA	300	IPV6: 2606:4700:3035::ac43:8668
gcmaf.se.	NS	86400	NS Record: liz.ns.cloudflare.com.
gcmaf.se.	NS	86400	NS Record: lex.ns.cloudflare.com.
gcmaf.se.	MX	300	MX Record: 0 dc-64d52f6d6271.gcmaf.se.
gcmaf.se.	TXT	300	TXT Record: v=spf1 ip4:77.73.68.85 +a +mx +ip4:77.73.68.85+include:servers.mcsv.net -all

HtmlToTextCheckTime:2023-05-13 05:49:38

Home Register Product Pricing Shipping Tests of GcMAF Participants’ Results Side Effects Treatment Protocols Treatment Protocols Diseases treated by GcMAF Autism Nagalase Blood Test Root Canals Cause Cancer Treatment Centres FAQ Why Us? The Science How GcMAF works 300 GcMAF Scientists Our Scientific Publications Immuno Biotech’s 40 papers Older research papers GcMAF: Scientific Proof Links The Controversy Diabetes & Obesity Blocking the VDR Beware of blogs Second Generation GcMAF Who We Are News Videos Contact GcMAF – the cancer cure the world has waited for GcMAF for inflammation, infections, viral and immune diseases. Register to Buy Science Research papers published Register to Buy Cancer The body’s way of becoming cancer free Register to Buy Quality No side effects Register to Buy GcMAF is the body’s own internal medicine. ALL healthy people have it. There are 180 eminent scientists who have published GcMAF research papers on the US National Library of Medicine alone. Sign the

Ads.txtCheckTime:2023-05-13 05:49:38

google.com, pub-3457508645636911, DIRECT,

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Mon, 20 Dec 2021 20:27:18 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
cache-control: private, max-age=0, must-revalidate, no-cache, no-store
display: staticcontent_sol, orig_site_sol
expires: Sun, 19 Dec 2021 20:27:18 GMT
pagespeed: off
vary: Accept-Encoding,Origin
x-middleton-display: staticcontent_sol, orig_site_sol
x-redirect-by: WordPress
x-sol: orig
location: https://gcmaf.se/
CF-Cache-Status: DYNAMIC
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=NmXhhFuPlMi8bJSR07Zbq2HyRR8RP003v7sFUAToqq7pdpCF0j2xvNZzjA7qdNyZa1mMKTtUjlmORjMpUazuMZbjvVT0ApJtawVricwRd1KKvyg31S8vKLEBzw%3D%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6c0b9c47ccf00c99-EWR
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

HTTP/2 200 
date: Mon, 20 Dec 2021 20:27:20 GMT
content-type: text/html; charset=UTF-8
cache-control: private, max-age=0, must-revalidate, no-cache, no-store
display: orig_site_sol
expires: Sun, 19 Dec 2021 20:27:19 GMT
link: ; rel=shortlink
pagespeed: off
vary: Accept-Encoding
x-middleton-display: orig_site_sol
x-sol: orig
set-cookie: ezoadgid_188546=-1; Path=/; Domain=gcmaf.se; Expires=Mon, 20 Dec 2021 20:57:19 UTC
set-cookie: ezoref_188546=; Path=/; Domain=gcmaf.se; Expires=Mon, 20 Dec 2021 22:27:19 UTC
set-cookie: ezosuibasgeneris-0=a5d01c7340c4fb5c80b7820044141b59; Path=/; Domain=gcmaf.se; Expires=Tue, 20 Dec 2022 20:27:19 UTC; Secure; SameSite=None
set-cookie: ezoab_188546=mod1-c; Path=/; Domain=gcmaf.se; Expires=Mon, 20 Dec 2021 22:27:19 UTC
set-cookie: lp_188546=https://gcmaf.se/; Path=/; Domain=gcmaf.se; Expires=Mon, 20 Dec 2021 20:57:19 UTC
set-cookie: ezovuuidtime_188546=1640032039; Path=/; Domain=gcmaf.se; Expires=Wed, 22 Dec 2021 20:27:19 UTC
set-cookie: ezovuuid_188546=7f728991-ad46-4e79-42ca-de1677126411; Path=/; Domain=gcmaf.se; Expires=Mon, 20 Dec 2021 20:57:19 UTC
set-cookie: ezopvc_188546=1; Path=/; Domain=gcmaf.se; Expires=Mon, 20 Dec 2021 20:57:19 UTC
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=4yG2zLZPsbh4W4tTDY5ojA1YpoatlPTnhU2BJFM61VOzre%2FaVuR4OtXaBtvsBSYOCvjzqwp3Cj3c1GZppeusLJnQdFkxrl%2F0UOOGZi3lm2Kz8EL11DBHj8SPtQ%3D%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6c0b9c50a82832ca-EWR
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

gcmaf.se Whois Information

#
state:            active
domain:           gcmaf.se
holder:           (not shown)
admin-c:          -
tech-c:           -
billing-c:        -
created:          2013-05-24
modified:         2021-05-17
expires:          2022-05-24
nserver:          lex.ns.cloudflare.com
nserver:          liz.ns.cloudflare.com
dnssec:           unsigned delegation
registry-lock:    unlocked
status:           ok
registrar:        Gandi SAS

gcmaf.se valuation and analysis